Analysis reveals radiomics can effectively distinguish lung adenocarcinoma from squamous cell carcinoma in non-small cell lung cancer, suggesting potential for clinical application.
Background: This study evaluates the effectiveness of radiomics based on 18F-fluorodeoxyglucose positron emission tomography/computed tomography ( 18 F-FDG PET/CT) in distinguishing lung adenocarcinoma from squamous cell carcinoma, the 2 major subtypes of non-small cell lung cancer (NSCLC). Methods: We extracted radiomic features from both the intratumoral and peritumoral areas in NSCLC patients’ PET/CT scans. The intratumoral volume of interest (VOI_I) was manually outlined on PET/CT images. Additionally, 4 peritumoral VOIs (VOI_P) were automatically generated by expanding VOI_I by 1, 2, 3, and 4 mm. A total of 107 radiomic features were extracted from each VOI. Feature selection was conducted using the t test, Spearman correlation analysis, and the least absolute shrinkage and selection operator. Subsequently, radiomics models (VOI_I model, VOI_P model, and a combined model) were constructed. The models’ performance was assessed by the area under the curve (AUC). Results: In the training set, the intratumoral (VOI_PET_I) model achieved the highest AUC (0.973), followed by the peritumoral 1 mm (VOI_PET_P1) model (AUC = 0.952). However, in the independent testing set, the VOI_PET_P1 model outperformed the VOI_PET_I model, achieving the highest AUC of 0.931 versus 0.920, respectively. This suggests that the peritumoral 1 mm region may provide superior generalizability for subtype classification in unseen data. Conclusion: In this study, radiomics features extracted from both intratumoral and peritumoral regions on 18F-FDG PET/CT demonstrated high predictive value for classifying NSCLC pathological subtypes. Notably, the 1 mm peritumoral region exhibited the best performance for differentiating lung adenocarcinomas, especially in the independent testing cohort. However, these findings are based on a single-center cohort with a limited sample size and require further validation in larger, multicenter studies to confirm their clinical utility and generalizability.
No takes yet. Share an insight, caveat, or question.
Qin et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: